Advertisement

Specialty Drug Growth Continues: A Look at the Pipeline

Key specialty pharmaceuticals market trends include increased competition along with cancer and orphan drug development, according to Aimee Tharaldson, PharmD, senior clinical consultant of emerging...

How to Design and Implement Value-Based Contracts

Value-based contracts are written contractual agreements in which the payment terms for medications or other health care technologies are tied to agreed‐upon...

Regulatory Guidance on Biosimilar Development, Plus a Look at the Biosimilar Pipeline

Eighteen biosimilars have been licensed by the Food and Drug Administration (FDA) since 2015, seven of which have launched. When submitting a...

Health Care Legislation: What’s to Come?

Health care remains a hot political issue, and it was ranked the top concern among voters in the 2018 midterm elections. With a...

How Will the U.S. Pay for Gene Therapies?

Gene therapy involves introducing genetic material into cells to compensate for abnormal genes or to make a beneficial protein. However, this is a very...

Payer and Manufacturer Perspectives for Agreeing on Value-Based Contracts in Medicaid

The need for value-based contracts for Medicaid plans has grown as a response to increasing prescription drug spending, more costly specialty medications, and finite...
Advertisement